Second-line treatment with nivolumab, cabozantinib, regorafenib, or best supportive care in patients with advanced hepatocellular carcinoma: analysis at a Hispanic-majority NCI-designated cancer center
@article{JGO58508, author = {Jeffrey Xia and Jonathan Gelfond and Sukeshi Patel Arora}, title = {Second-line treatment with nivolumab, cabozantinib, regorafenib, or best supportive care in patients with advanced hepatocellular carcinoma: analysis at a Hispanic-majority NCI-designated cancer center}, journal = {Journal of Gastrointestinal Oncology}, volume = {12}, number = {6}, year = {2021}, keywords = {}, abstract = {}, issn = {2219-679X}, url = {https://jgo.amegroups.org/article/view/58508} }